Idiopathic Intracranial Hypertension (IIH)
10
5
5
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (10)
Stenting Of Symptomatic Cerebral siNus stenosIs With the laserCut Self-expanding SILANCE Stent
BMI in Idiopathic Intracranial Hypertension and Its Relationship With the Response to Treatment
Venous Stenting Evaluation in Patients With Intracranial Hypertension Under Long-term Acetazolamide
Tirzepatide in Idiopathic Intracranial Hypertension Trial
Intracranial Venous Stenting Evaluation in Patients With Idiopathic Intracranial Hypertension in the Early Phase
Advanced Neuroimaging in Idiopathic Intracranial Hypertension
Dural Venous Sinus Stent in Idiopathic Intracranial Hypertension
VEHICLE Registry: Venous Stenting for IIH in the MENA Region
Operative Procedures Vs. Endovascular Neurosurgery for Untreated Pseudotumor Trial
Venous Sinus Stenting for Idiopathic Intracranial Hypertension Refractory to Medical Therapy